Cargando…
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China
The ongoing COVID-19 pandemic has resulted in millions of deaths globally, highlighting the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2. Small molecule inhibitors (remdesivir, Paxlovid, and molnupiravir) are essential complements to vaccines and play important r...
Autores principales: | Yang, Liyan, Wang, Zhonglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193775/ https://www.ncbi.nlm.nih.gov/pubmed/37229831 http://dx.doi.org/10.1016/j.ejmech.2023.115503 |
Ejemplares similares
-
Co-crystallization and structure determination: An effective direction for anti-SARS-CoV-2 drug discovery
por: Wang, Zhonglei, et al.
Publicado: (2021) -
From bedside to bench: regulation of host factors in SARS-CoV-2 infection
por: Ong, Samantha Y. Q., et al.
Publicado: (2021) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts
por: Wang, Zhonglei, et al.
Publicado: (2021) -
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection
por: Wang, Zhonglei, et al.
Publicado: (2023)